3Martinez-Rumayor A, Richards A M, Burnett J C, et al. Biology of the natriuretic peptides [J]. Am J Cardiol,2008,101 (Suppl A) :3A-8A.
4Verouden N J,Haeek J D, Kuijt W J, et al. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention [J]. Am J Cardiol, 2010, 105(8) : 1047-1052.
5Dominguez-Rodriguez A, Abreu-Gonzalez P, Avanzas P, et al. Neopterin predicts left ventricular remodeling in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention [J]. Atherosclerosis, 2010, 211(2) :574-578.
6Hildebrandt P.Natriuretic peptides: prediction of cardiovascular disease in the general population and high risk populations [J]. Dis Markers, 2009, 26(5-6): 227-233.
7Lee SH,Jung JH,Choi SHet al.Determinants of brain natri—ureticpeptide levels in patients with lone atrial fibrillation. Circulation Journal . 2006
8Shibazaki K,Kimura K,Okada Yet al.Plasma brain natriuretic peptide as an independent predictor of in-hospital mortality after acute ischemic stroke. Journal of Internal Medicine . 2009
9DeGraba TJ,Hallenbeck JM,Pettigrew KD,et al.Progression in acute stroke value of the initial NIH stroke scale score on patient stratification in future trials (J). Stroke . 1999
10Panteghini M.Role and important of biochemical marker in clinical cardiology. European Heart Journal . 2004
